Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 26:129.
doi: 10.48101/ujms.v129.10614. eCollection 2024.

Unboxing the network among long non-coding RNAs and TGF-β signaling in cancer

Affiliations
Review

Unboxing the network among long non-coding RNAs and TGF-β signaling in cancer

Dorival Mendes Rodrigues-Junior et al. Ups J Med Sci. .

Abstract

Deeper analysis of molecular mechanisms arising in tumor cells is an unmet need to provide new diagnostic and therapeutic strategies to prevent and treat tumors. The transforming growth factor β (TGF-β) signaling has been steadily featured in tumor biology and linked to poor prognosis of cancer patients. One pro-tumorigenic mechanism induced by TGF-β is the epithelial-to-mesenchymal transition (EMT), which can initiate cancer dissemination, enrich the tumor stem cell population, and increase chemoresistance. TGF-β signals via SMAD proteins, ubiquitin ligases, and protein kinases and modulates the expression of protein-coding and non-coding RNA genes, including those encoding larger than 500 nt transcripts, defined as long non-coding RNAs (lncRNAs). Several reports have shown lncRNAs regulating malignant phenotypes by directly affecting epigenetic processes, transcription, and post-transcriptional regulation. Thus, this review aims to update and summarize the impact of TGF-β signaling on the expression of lncRNAs and the function of such lncRNAs as regulators of TGF-β signaling, and how these networks might impact specific hallmarks of cancer.

Keywords: Cancer; epigenetics; non-coding RNA; signal transduction; transforming growth factor-β.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest for this article.

Figures

Figure 1
Figure 1
Network of lncRNAs and TGF-β signaling in cancer. TGF-β binds to the type II and type I receptors (TβRs) on the cell surface, signaling via inter-receptor trans-phosphorylation. The type I receptor phosphorylates SMAD2/3, which promotes their oligomerization with SMAD4 (presented for simplicity as SMAD), and in parallel, TGF-β signaling induces RAS, MEK, ERK, and other protein kinase pathways (not shown), that, together with transcription factors (TFs), regulate the expression of lncRNAs (shown as multicolor single-stranded molecules in order to emphasize the diversity of the implicated lncRNA species). According to the respective cellular compartment, lncRNAs modulate TGF-β signaling at different steps. Nuclear lncRNAs act as (i) guide or decoy molecules for TF complexes to promote gene transcription (TSS, transcription start site) (ii) as DNA binding molecules inducing triple helix formations or (iii) facilitate protein translocation from one compartment to another. Cytoplasmic lncRNAs can regulate (iv) mRNA stability, (v) can act as scaffolds, stabilizing protein-RNA complexes, or (vi) can regulate mRNA translation and stability through competitive endogenous RNA (ceRNA) function against microRNAs (miRNAs). LncRNAs are also sorted as cargo in intraluminal vesicles of multivesicular bodies (MVBs), which release their lncRNA content into the extracellular milieu. Created with BioRender.com. TGF-β, transforming growth factor β; IncRNA, long non-coding RNAs.

Similar articles

Cited by

References

    1. Li P, Elowitz MB. Communication codes in developmental signaling pathways. Development. 2019;146(12):dev170977. doi: 10.1242/dev.170977 - DOI - PMC - PubMed
    1. Massagué J, Sheppard D. TGF-b signaling in health and disease. Cell. 2023;186(19):4007–37. doi: 10.1016/j.cell.2023.07.036 - DOI - PMC - PubMed
    1. Morikawa M, Koinuma D, Miyazono K, Heldin C-H. Genome-wide mechanisms of Smad binding. Oncogene. 2013;32(13):1609–15. doi: 10.1038/onc.2012.191 - DOI - PMC - PubMed
    1. Papoutsoglou P, Moustakas A. Long non-coding RNAs and TGF-b signaling in cancer. Cancer Sci. 2020;111(8):2672–81. doi: 10.1111/cas.14509 - DOI - PMC - PubMed
    1. Morikawa M, Derynck R, Miyazono K. TGF-b and the TGF-b family: context-dependent roles in cell and tissue physiology. Cold Spring Harb Perspect Biol. 2016;8(5):a021873. doi: 10.1101/cshperspect.a021873 - DOI - PMC - PubMed

MeSH terms

Substances